Webinar: Psilocybin in Depression: Insights From Contemporary Clinical Trials
We would like to warmly invite you to the upcoming webinar organized by the Psychedelics Pharmacology Global Networking Community (GNC).
Psilocybin in Depression: Insights From Contemporary Clinical Trials
Led by Dr. Joshua D. Rosenblat and Dr. Danica Johnson (University of Toronto & University Health Network, Canada), this webinar will provide a critical overview of efficacy, safety, and the methodological considerations shaping this rapidly evolving field.
The webinar will cover the following main objectives:
- Critically evaluate the current clinical trial evidence on psilocybin as a treatment for depression, including efficacy, safety, and methodological strengths and limitations
- Outline the regulatory, ethical, and operational steps involved in designing and conducting supervised, compliant psilocybin clinical trials.
- Examine emerging issues, debates, and unresolved questions shaping the future of psilocybin clinical research.
We warmly encourage you to register and join us for this session, which will offer valuable insights and thought-provoking discussions for all those interested in the evolving field of psychedelic research.
Click to Register for the Webinar
After registering, you will receive a confirmation email containing the link and information about joining the webinar. If you have any questions, please don’t hesitate to contact us at info@cinp.org
